Showing results (11-20 of 333) with videos related to

Sort By:
Pageof 34
Drugs|January 1, 1994
Hormone replacement therapy and the cardiovascular system. Nonlipid effectsJ C Stevenson, D Crook, I F Godsland, et al.
Fertility and Sterility|September 1, 1995
Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trialR Howell, D K Edmonds, M Dowsett, et al.
Hormone Research|January 1, 1989
Zoladex versus danazol in the treatment of pelvic endometriosis: effects on plasma lipid risk factorsD Crook, R Gardner, M Worthington, et al.
The American Journal of Medicine|November 1, 1995
Body fat distribution, rather than overall adiposity, influences serum lipids and lipoproteins in healthy men independently of ageC Walton, B Lees, D Crook, et al.
Fertility and Sterility|March 1, 1993
A randomized comparative study of the metabolic effects of two regimens of gestrinone in the treatment of endometriosisM Worthington, L M Irvine, D Crook, et al.
Journal of the American College of Cardiology|February 1, 1994
Insulin resistance, lipoproteins, body fat and hemostasis in nonobese men with angina and a normal or abnormal coronary angiogramC J Ley, J Swan, I F Godsland, et al.
Obstetrics and Gynecology|January 1, 1994
Effect of continuous combined estrogen and desogestrel hormone replacement therapy on serum lipids and lipoproteinsM S Marsh, D Crook, S I Whitcroft, et al.
Lancet (London, England)|July 8, 1995
Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal womenA J Proudler, A I Ahmed, D Crook, et al.
British Heart Journal|January 1, 1994
Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese menJ W Swan, C Walton, I F Godsland, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1995
Serum angiotensin-I-converting enzyme activity in women with cardiological syndrome X: relation to blood pressure and lipid and carbohydrate metabolic risk markers for coronary heart diseaseA J Proudler, D Crook, I F Godsland, et al.
Pageof 34